在初级中性粒细胞中通过in-172抑制CFTR揭示了CFTR特异性的功能缺陷
Ana Lúcia Da Silva Cunha1,2, Marfa Blanter3, Janne Renders3
1Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.
Scientific reports
|December 29, 2024
概括
中性粒细胞中CFTR功能的丧失会损害关键的抗微生物功能,包括菌体酸化,杀死细菌和反应性氧物种的产生,导致囊性纤维化患者未解决的感染.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 囊性纤维化 (CF) 涉及重复的细菌感染和肺部炎症.
- 中性粒细胞的透过多,但在CF中,感染仍未解决.
- CFTR蛋白在中性粒细胞功能中的特定作用尚未完全理解.
研究的目的:
- 调查哪些抗微生物功能直接受到中性粒细胞CFTR功能丧失的影响.
- 为了区分CFTR特异性缺陷与CF中性粒细胞中的其他因素.
主要方法:
- 在中性粒细胞中利用CFTR抑制剂 (INH-172) 来模拟CFTR功能障碍.
- 从患有囊性纤维化 (PwCF) 和严重CFTR突变的人群中分离出的中性粒细胞.
- 评估中性粒细胞的功能,包括细胞形成,ROS产生,脱粒化 (NE,MPO) 和杀死细菌.
- 与CF唾液超和气道上皮细胞共培养的中性粒细胞.
主要成果:
- 抑制剂模型显示,体酸化减少,细菌存活率增加,ROS产量减少.
- PwCF中性粒细胞表现出中性粒细胞弹性酶 (NE) 和髓氧化酶 (MPO) 降低.
- 当中性粒细胞暴露在CF炎症环境中时,化细胞减少.
- 在受抑制剂治疗和CF中性粒细胞中都观察到功能缺陷,尽管CFTR表达低.
结论:
- 失去了CFTR功能直接损害了关键的中性粒细胞抗菌机制.
- 这些缺陷有助于囊性纤维化特征的未解决的感染.
- CFTR抑制剂模型提供了一种可靠的方法来研究CFTR特异性中性粒细胞功能障碍,最大限度地降低了供体变异性.
更多相关视频
15:12Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
14.4K
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
19.1K
相关概念视频
Cystic Fibrosis: Pathogenesis
135
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
135
Cystic Fibrosis: Management
94
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
94
